ANIMPORTEXOSEAS(P)LTD
Leave no citizen behind in the journey towards a healthier nation.
The obsession with innovative healthcare solutions has made us the most prescribed pharma company in india.We are architects of the future , setting new benchmarks in pharmaceutical excellence with drug discovery ,advanced formulations,generic ApIs,and biotechnology,Vaccine,Tablet,capsule,Injection,Herbal and ayurvedic.
About us
The Pursuit of a Healthier Bharat Fueled by Science
Anim Pharmaceutical Industries Ltd. (Anim Pharma) is the largest specialty generic pharmaceutical company in the world with global revenues of US$ billion. Supported by 41 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Watch the inspiring growth story of Anim – from humble beginnings in 2022 with just 3 employees and 4 psychiatry products to becoming the largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.
Founder & Director
Reaching People And Touching Lives Globally As A Leading Provider Of Valued Medicines
Diversified Specialty and Generics Portfolio
We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Our broad portfolio of more than 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Every year, we sell over 30 billion doses covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology and respiratory among others Our non-compromising approach to quality ensures that we are constantly endeavoring to achieve and maintain the highest quality standards in the pharmaceutical industry in India.
Driven by Innovation
The first among Indian pharmaceutical companies to realise and embrace the importance of investing in research, we invest up to 6-8% of our global revenues into Research and Development (R&D) every year. Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development. Our capabilities extend beyond the development of differentiated products, including lipasamal products, inhalers, yophilized injections, nasal sprays, and controlled release dosage forms. Our R&D team comprises over 3,000 people.aNIMology, a combination of Anim and Ideology is the way of life at Anim Pharma.Staying true to our founding principles of being a price disruptor, we deliver affordable medication that meets the healthcare needs of Bharat.
Global Footprint
From humble beginnings in 2019, aNIM Pharma has grown to become one of the largest generic pharmaceutical companies worldwide. We are the largest pharmaceutical company in India. In the US, we are among the leading generic pharmaceutical companies and are ranked second by prescriptions in the generic dermatology market. We are the largest Indian company in emerging markets with a presence in over 80 markets. Brazil, Mexico, Russia, Romania and South Africa are some of our key emerging markets. We are present across all major markets in Western Europe, Canada, Australia, New Zealand, Japan and China among others. Our presence in emerging markets and the developing world enables our teams to cross-sell and build brands with ease.More than 50% of India’s total population resides in villages, making access to medicines difficult. AnimglobalPharma pioneering use of supply chains and a company-owned distribution setup bolsters accessibility.
Health Care
We seek out, and solve, tough challenges.
01
Humility
Under promise and over deliver Let your work speak for you Always put ‘we’ before ‘me’ Learn from mistakes
02
Integrity
Do the right thing with conviction and without fear Practice honesty, impartiality and fairness at all times Adhere to strong ethical and moral standards Have courage to call out what is not right
03
Passion & Innovation
Strive to implement new ideas & technologies to meet unmet needs Encourage others to think out-of-the-box Do not limit yourself Believe in raising the bar every time
Anim, a combination of Anm and Anim is the way of life at Animglobal Pharma.
Our Business Verticals
We excel in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. We excel in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Quality
Get it right the first time
Trust
Be transparent in dealings
Reliability
Maintain efficiency & discipline in all processes & systems and fulfil the promises made to stakeholders
Innovation & Consistency
Endeavour to bring new products to the market & consistently deliver value to stakeholdersImplement new ideas & technologies to meet unmet needs and think ahead of times
Committed to Creating Value for People and Planet
Our Research Philosophy
Science is at the heart of aNIM. Our scientists work closely with doctors, patients and the business development teams to generate innovative concepts and ideas to harness both, market needs and synergies across therapeutic areas. Whether it is specialty, generics, difficult to make technology intensive products, Active Pharmaceutical Ingredients (APIs) or Novel Drug Delivery Systems (NDDS), our scientists have the capability to deliver high quality products to fulfil the unmet need in the marketplace. Our R&D team comprises over 2,800 people working in six research centers across India, Israel, USA and Canada who have a passion for innovation and longing to provide better healthcare to humanity at large.
Strong Intellectual Property
Our research strategy and implementation are well supported by a strong intellectual property team having expertise and experience in chemistry, analytical techniques, dosage forms and global patent law. aNIM files numerous patents every year to protect its intellectual property in markets of interest. We have close to 2600 patents to our credit. Our R&D centres have been audited and approved by international regulatory authorities, including the US FDA and European authorities. The R&D centers at Vadodara, & Gurgaon in India are certified by the National GLP Compliance Monitoring Authority.
Malaria Elimination
Our Malaria Elimination Demonstration Project (MEDP) is a first-of-its-kind Public-Private partnership between the Indian Council of Medical Research (ICMR), Government of Madhya Pradesh (GoMP), and the Foundation for Disease Elimination and Control of India (FDEC India). FDEC India was established by Sun Pharmaceutical Industries Ltd. as a not-for-profit entity. Culminated in 2022, the MEDP achieved reduction of 91% in indigenous malaria cases in over 1100 villages of the Mandla district.
Technology
Our capabilities span the development of differentiated products including liposomal delivery, inhalers, lyophilised injections, nasal sprays besides developing controlled and modified release dosage forms. We are also pioneers in delivery systems of ophthalmology, cardiology, peptides, CNS and oncology. Our knowledge in pharmaceutical research allows a rapid ramp-up of a diverse range of immediate and Novel Delivery Systems spanning oral, parenteral, topical and inhalation dosage forms. Our formulation expertise lies in the areas of taste masking, spray-drying, drug-layering, nano-milling among others. The ability to develop difficult-to-make, complex APIs by using latest technologies is the key differentiating factor of our research.
Innovation
Our early investments in R&D, beginning over three decades ago has enabled us to make technology a key differentiator. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development.
Environment, Health and Safety
At Animglobal Pharma, we remain fully committed to achieving excellence through our Environmental, Health & Safety (EHS) programmes. Conducting our activities in a responsible, proactive manner is a core focus of our operations and culture. As a part of this commitment, our EHS Policy provides for the creation of a safe and healthy workplace and a clean environment for all employees and our served communities. Aiming for, and adhering to, the highest international standards in plant design, equipment selection, maintenance, and operations, our EHS policy is a core commitment of our operations. We have established an ISO14001:2015 compliant Environmental Management System and ISO 45001:2018 compliant Occupational Health and Safety Management System at our key manufacturing facilities.
At Animglobal Pharma, we live our values of quality, reliability, consistency, trust and innovation.
These values form the core of our culture and steer us towards our vision of reaching people and touching lives globally as a leading provider of valued medicines.
